Asahi Group Foods
Tokyo, Japan
Profile updated: April 2, 2026
Asahi Group Foods, Ltd. is a Japanese food and health ingredients company and a subsidiary of Asahi Group Holdings, headquartered in Tokyo, Japan. The company produces functional ingredients derived from decades of fermented milk research, including AmealPeptide (lactotripeptide for cardiovascular support, FDA GRAS) and CP2305 (Lactobacillus gasseri CP2305 postbiotic for stress, mood, and sleep support). CP2305 is exclusively distributed in the US by ADM under a February 2025 agreement. Other branded ingredients are distributed in the US through Maypro Industries. In 2025, Asahi Group acquired Leiber GmbH (German brewers' yeast refiner) and Asahi Meguro Institute to strengthen its lactic acid bacteria capabilities.
Directory Listing — Records Reviewed
Public records and independent sources have been reviewed.
What this means →Min. OrderMOQ (Minimum Order Quantity)The smallest production run a manufacturer will accept for an order.
Not publicly disclosed
Lead TimeLead TimeThe time from order placement to finished product delivery.
Not publicly disclosed
Product Types
AmealPeptide (Lactotripeptide, Cardiovascular Support), CP2305 (L. gasseri Postbiotic, Stress/Sleep), L-92 (L. acidophilus L-92, Immune Support), Lactic Acid Bacteria Ingredients
Capabilities
Fermented Milk-Derived Functional Ingredients, Lactic Acid Bacteria Research (40+ Years), Postbiotic Development, US Distribution via ADM (CP2305) and Maypro, FDA GRAS Ingredients
Certifications
0 of 1 certification independently confirmed. What this means
Key Regulatory Concepts
Dietary supplement manufacturers must comply with 21 CFR Part 111 (Current Good Manufacturing Practice for dietary supplements). This includes requirements for personnel, facilities, equipment, production, laboratory operations, and record-keeping.
Review Notes
Japanese food and health ingredients company (Asahi Group Holdings subsidiary), Tokyo HQ. Produces functional ingredients from fermented milk research: AmealPeptide (FDA GRAS lactotripeptide), CP2305 (postbiotic, exclusive ADM US distribution per Feb 2025 agreement), L-92 (immune probiotic). 2025 acquisitions: Leiber GmbH (Germany) and Asahi Meguro Institute. US distribution via ADM and Maypro. ADM press release and Asahi corporate website confirm supplement ingredient supply.
Sources
- Asahi Group Foods — Business Overview(2026-04-02)
- ADM and Asahi Group CP2305 Distribution Agreement(2026-04-02)
Disclosures
- No material connection exists between Inventory Ready and this company
Interested in Asahi Group Foods?
Tell us about your project and we'll help you determine if this ingredient supplier is a good fit.